Bio-Techne (TECH) EBIT Margin (2009 - 2026)

Bio-Techne's EBIT Margin history runs 18 years deep, the most recent figure standing at 24.24% for Q1 2026.

• In Q1 2026, EBIT Margin rose 1200.0% year-over-year to 24.24%; the TTM figure through Mar 2026 stood at 12.7% (down 153.0% YoY), while the FY2025 annual figure was 8.38%, down 945.0% from the prior year.
• EBIT Margin was 24.24% for Q1 2026 at Bio-Techne, up from 18.41% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 2815.85% in Q3 2022 to a low of 7.53% in Q2 2025.
• Historically, EBIT Margin has averaged 183.74% across 5 years, with a median of 20.17% in 2023.
• The sharpest annual moves came in 2022 and 2023: EBIT Margin soared 279132 bps in 2022, then slumped 279568 bps in 2023.
• A 5-year view of EBIT Margin shows it stood at 25.0% in 2022, then slumped by 44 bps to 13.94% in 2023, then grew by 15 bps to 15.96% in 2024, then increased by 15 bps to 18.41% in 2025, then surged by 32 bps to 24.24% in 2026.
• The last three EBIT Margin figures came in at 24.24% (Q1 2026), 18.41% (Q4 2025), and 16.63% (Q3 2025), per Business Quant data.